Is inhaled budesonide an effective treatment for patients with mild early symptoms of COVID-19?

CJEM. 2021 Sep;23(5):611-612. doi: 10.1007/s43678-021-00154-3. Epub 2021 Jul 19.

Authors

Hashim Kareemi¹, Hans Rosenberg², Krishan Yadav^{2

3}

Affiliations

¹ Department of Emergency Medicine, University of Ottawa, Ottawa, ON, Canada. hkareemi@toh.ca.
² Department of Emergency Medicine, University of Ottawa, Ottawa, ON, Canada.
³ Ottawa Hospital Research Institute, Ottawa, ON, Canada.

No abstract available

Keywords: Budesonide; COVID-19; RCT; Steroids.

Publication types

Editorial
Comment

MeSH terms

Administration, Inhalation
Bronchodilator Agents / therapeutic use
Budesonide*
COVID-19*
Humans
SARS-CoV-2

Substances

Bronchodilator Agents
Budesonide